Of the CD34+CD10− population, the values of the subpopulations with a stable or increased percentage were 5 and 0 in 2 pro-B-ALL patients, respectively, which were obviously reduced compared to the common ALL patients. The gene discussed is CD34; the disease is acute lymphoblastic leukemia.